| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 01/30/2002 | EP0528857B1 New bacillus thuringiensis strain and its gene encoding insecticidal toxin |
| 01/30/2002 | CN1333872A Apparatus and method for measuring Nox and nutrifiation/denitrification retes in biochemical processes |
| 01/30/2002 | CN1333837A Methods for producing polypeptides in aspergillus mutant cells |
| 01/30/2002 | CN1333836A Substances WK-5344A and WK-5344B and process for producing the same |
| 01/30/2002 | CN1333833A New method of identifying non-host plant disease resistance genes |
| 01/30/2002 | CN1333832A Compounds and methods for treatment and diagnosis of chlamydial infection |
| 01/30/2002 | CN1333831A Polymorphic loci that differentiate escherichia coli 0157:H7 from other strains |
| 01/30/2002 | CN1333830A Compositions and methods for therapy and diagnosis of ovarian cancer |
| 01/30/2002 | CN1333826A Subtilase enzymes of the I-S1 and I-S2 sub-group having an additional amino acid residue in an active site loop region |
| 01/30/2002 | CN1333825A Subtilase enzymes of the I-S1 I-S2 sub-groups having an additional amino acid residue in an active site loop region |
| 01/30/2002 | CN1333824A Subtilase enzymes of the I-S1 and I-S2 sub-groups having and additional amino acid residue in an active site loop region |
| 01/30/2002 | CN1333823A Subtilase enzymes of the I-S1 and I-S2 sub-groups having an additional amino acid residue in an active site loop region |
| 01/30/2002 | CN1333822A Subtilase enzymes of the I-S1 and I-S2 sub-groups having an additional amino acid residue in an active site loop region |
| 01/30/2002 | CN1333821A Alpha-amylse variant |
| 01/30/2002 | CN1333820A Recombinant methods and materials for producing epothilone and eopthilone derivatives |
| 01/30/2002 | CN1333819A Method for high level expression of active lymphotoxin-betareceptor immunoglobulin |
| 01/30/2002 | CN1333811A Subtilase enzymes of the I-S1 and I-S2 sub-groups having an additional amino acid residue in the active site loop region |
| 01/30/2002 | CN1333785A Interferon-beta fusion proteins and uses |
| 01/30/2002 | CN1333371A Enzyme method preparation for high-purity oligoxylose |
| 01/30/2002 | CN1333363A Phytase gene sequence and application in yeast thereof |
| 01/30/2002 | CN1333336A River vibrio and process for producing algion lyase by using the same |
| 01/30/2002 | CN1333335A Method for preparing probiotics by co-fermentation of probiotics and fungus |
| 01/30/2002 | CN1078452C Flavored yeast extracts, productive method |
| 01/29/2002 | US6342596 Molecular regulatory circuits to achieve sustained activation of genes of interest by a single stress |
| 01/29/2002 | US6342584 Antiproliferative, anticarcinogenic, antitumor, antiinflammatory, and antimetastasis agents; diabetes, restenosis, rheumatoid arthritis treatment; genetic engineering |
| 01/29/2002 | US6342583 Polypeptide genetically expressed by cell that is transfected, infected, or injected with cloning vehicle; genetic engineering; colorectal cancer tumor markers |
| 01/29/2002 | US6342581 Genetic engineering and expression of polynucleotides and polypeptides; vectors, cells, antibodies for diagnosis and disease treatment |
| 01/29/2002 | US6342382 Purified nucleic acid; complementarity; washing follow hybridization; genetic engineering and expression |
| 01/29/2002 | US6342375 Modified methylotrophic Pichia pastoris yeast which secretes human growth hormone |
| 01/29/2002 | US6342369 Polypeptides, designated apo-2, which are capable of modulating apoptosis are provided |
| 01/29/2002 | US6342368 WD-40-derived peptides and uses thereof |
| 01/29/2002 | US6342366 Bactericides |
| 01/29/2002 | US6342363 Death domain containing receptor 4 nucleic acids and methods |
| 01/29/2002 | US6342351 Methods and compositions for diagnosing and treating chromosome-18p related disorders |
| 01/29/2002 | US6342224 For prophylaxis and therapy of human papilloma induced tumours |
| 01/29/2002 | US6342222 Equine arteritis virus peptides, antibodies and their use in a diagnostic test |
| 01/29/2002 | US6342215 Mutant microorganism having reduced adaptation to particular environment; avirulent pathogens for vaccines |
| 01/29/2002 | CA2174745C Keto group introducing enzyme, dna coding for the same, and process for producing ketocarotenoids |
| 01/29/2002 | CA2155330C Human neuronal nicotinic acetylcholine receptor compositions and methods employing same |
| 01/24/2002 | WO2002006532A1 Novel dna polymerase iii holoenzyme delta subunit nucleic acid molecules and proteins |
| 01/24/2002 | WO2002006529A2 Detection and treatment of polycystic kidney disease |
| 01/24/2002 | WO2002006503A2 Process for generation of hydrogen gas from various feedstocks using thermophilic bacteria |
| 01/24/2002 | WO2002006502A2 Adenovirus vectors comprising introns |
| 01/24/2002 | WO2002006494A1 Recombinant plasmid pdsbcm, microorganisms transformed therewith, and method for producing an alkaline protease vapk |
| 01/24/2002 | WO2002006493A1 Recombinant plasmid psp1, microorganisms transformed therewith, and method for producing an alkaline protease vapk |
| 01/24/2002 | WO2002006492A1 A novel human soluble secreted endopeptidase (sep) for the treatment of sexual dysunfction |
| 01/24/2002 | WO2002006490A1 Lipoxygenase genes, promoters, transit peptides and proteins thereof |
| 01/24/2002 | WO2002006483A1 Novel physiologically active peptide and use thereof |
| 01/24/2002 | WO2002006482A1 Receptor protein specifically recognizing bacterial dna |
| 01/24/2002 | WO2002006478A2 Extracellular matrix protein |
| 01/24/2002 | WO2002006468A2 METHYL CpG BINDING DOMAIN NUCLEIC ACIDS FROM MAIZE |
| 01/24/2002 | WO2002006466A1 Novel g protein-coupled receptor protein and dna thereof |
| 01/24/2002 | WO2002006463A2 Regulation of gene expression using single-chain, monomeric, ligand dependent polypeptide switches |
| 01/24/2002 | WO2002006462A2 Methylated nucleotide regulation of upa gene expression |
| 01/24/2002 | WO2002006461A2 Inhibitors of plant peptide deformylase for use as broad-spectrum herbicides and methods for identifying the same |
| 01/24/2002 | WO2002006456A1 Methods and compositions for rapid protein and peptide extraction and isolation using a lysis matrix |
| 01/24/2002 | WO2002006453A2 Regulation of human desc1-like serine protease |
| 01/24/2002 | WO2002006452A2 Cloning, sequencing and expression of a comamonas cyclopentanone 1,2-monooxygenase-encoding gene in escherichia coli |
| 01/24/2002 | WO2002006449A2 Method of detecting compounds that control fungal diseases via effects on sporulation |
| 01/24/2002 | WO2002006340A2 Tetraspan protein and uses thereof |
| 01/24/2002 | WO2002006328A2 Type 2 dendritic cell precursor derived coding nucleic acids and related compositions and methods |
| 01/24/2002 | WO2002006322A2 Polycomb genes mez1 and mez2 from maize |
| 01/24/2002 | WO2002006321A2 Polycomb gene zmfie2 from maize |
| 01/24/2002 | WO2002006317A2 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 01/24/2002 | WO2002006313A2 Regulation of human glutamate receptor delta-1 subunit |
| 01/24/2002 | WO2002006311A2 Olfactory g-protein coupled receptor |
| 01/24/2002 | WO2002006306A2 SUBSTRATES AND ASSAYS FOR β-SECRETASE ACTIVITY |
| 01/24/2002 | WO2002005843A2 Human rrp sequences and methods of use |
| 01/24/2002 | WO2002005655A1 Flavour product |
| 01/24/2002 | WO2002005651A1 Peroxide treated yeast extract and method of production |
| 01/24/2002 | WO2002005627A1 Ctr1 homologue from melon |
| 01/24/2002 | WO2001075111A3 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 01/24/2002 | WO2001064750A3 Modulation of the activity of the endothelial cel surface receptor ecrtp/dep-1 in the regulation of angiogenesis |
| 01/24/2002 | WO2001060838A3 Aids ancestral viruses and vaccines |
| 01/24/2002 | WO2001059115A3 83p5g4: a tissue specific protein highly expressed in prostate cancer |
| 01/24/2002 | WO2001055324A3 Nucleic acids, proteins, and antibodies |
| 01/24/2002 | WO2001055305A3 Nucleic acids, proteins, and antibodies |
| 01/24/2002 | WO2001051515A3 Genes differentially expressed in breast cancer |
| 01/24/2002 | WO2001046258A3 Transporters and ion channels |
| 01/24/2002 | WO2001042465A3 Chordin-like molecules and uses thereof |
| 01/24/2002 | WO2001039797A3 Artificial chromosome constructs containing nucleic acid sequences capable of directing the formation of a recombinant rna-virus |
| 01/24/2002 | WO2001034768A3 15 human secreted proteins |
| 01/24/2002 | WO2001032910A3 27 human secreted proteins |
| 01/24/2002 | WO2001031049A3 Production of polyketides |
| 01/24/2002 | WO2001029221A3 Proteins and polynucleotides encoding them |
| 01/24/2002 | WO2001025436A3 Endozepine-like polypeptides and polynucleotides encoding same |
| 01/24/2002 | WO2001025397A3 Compositions and methods for tumor-targeted delivery of effector molecules |
| 01/24/2002 | WO2001023409A8 38 human secreted proteins |
| 01/24/2002 | WO2001019860A3 Proteins associated with cell differentiation |
| 01/24/2002 | WO2001016290A3 Dna encoding the human serine protease eos |
| 01/24/2002 | WO2001014417A3 Pesticidal proteins |
| 01/24/2002 | WO2001012819A3 Protein phosphatases and diagnosis and treatment of phosphatase-related disorders |
| 01/24/2002 | WO2000073453A9 T-bet compositions and methods of use thereof |
| 01/24/2002 | WO2000073413A9 Apparatus and method for cell disruption |
| 01/24/2002 | US20020010328 Genetic engineering |
| 01/24/2002 | US20020010324 Genetic engineering; polypeptides |
| 01/24/2002 | US20020010318 Enzyme inhibitor; for use in treatment of lung defects, asthma, bronchitis, emphysema and respiratory system disorders |
| 01/24/2002 | US20020010136 Having an increased positive regulatory activity for expression of tyrosine phenol lyase gene, a gene coding for the same; biosynthesis of L-3,5-dihydroxyphenylalanine (L-DOPA) |
| 01/24/2002 | US20020009804 32705, 23224, 27423, 32700, 32712, novel human G-proteins |
| 01/24/2002 | US20020009792 Nucleotide sequences coding protein; for use in wastewater treatment |